Publications by authors named "Luke Probst"

Claim this Profile
A
Accuracy of 4 Free Online Dosing Calculators in Predicting the Vancomycin Area Under the Concentration-Time Curve Calculated Using a 2-Point Pharmacokinetic Approach.
Sarah N Belz, Robert W Seabury, Jeffrey M Steele, William Darko, Christopher D Miller, Luke A Probst

Ann Pharmacother· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic Enoxaparin in Critically Ill Trauma Patients: Evaluation of the Initial Dose.
Kaitlyn J Agedal, Elizabeth A Feldman, Robert W Seabury, William Darko, Luke A Probst

Hosp Pharm· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Andexanet alfa effectiveness and safety versus four-factor prothrombin complex concentrate (4F-PCC) in intracranial hemorrhage while on apixaban or rivaroxaban: A single-center, retrospective, matched cohort analysis.
Katie A Parsels, Robert W Seabury, Stephanie Zyck, Christopher D Miller, Satish Krishnamurthy, Luke A Probst

Am J Emerg Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of Methicillin-Resistant Staphylococcus aureus (MRSA) Risk Factors in Predicting MRSA Community-Acquired Pneumonia at an Academic Medical Center.
Joelle Arieno, Robert Seabury, Wesley Kufel, William Darko, Christopher D Miller, Luke A Probst

Hosp Pharm· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Direct Oral Anticoagulant Therapy in Patients With Cancer.
Lindsey M Fovel, Robert W Seabury, Christopher D Miller, William Darko, Luke A Probst

J Pharm Pract· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical and Physical Stability of an Admixture Containing Cefepime and Vancomycin in Lactated Ringer Solution.
Pegah Shakeraneh, Risako Robinson, Wesley D Kufel, L Nathan Tumey, Samantha R Benjamin, Luke A Probst

Hosp Pharm· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single-center cost analysis assessing a change in vasopressin formulation.
Courtney E Kelly, Christopher Miller, William Darko, Greg Cwikla, Bryan Mogle, Luke A Probst

Am J Health Syst Pharm· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a formal pharmacy residency research certificate program.
William Darko, Robert W Seabury, Christopher D Miller, Sarah A Spinler, Luke A Probst

Am J Health Syst Pharm· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent Renal Dysfunction Secondary to Probable Piperacillin-Tazobactam-Induced Acute Interstitial Nephritis.
Katie A Parsels, Robert W Seabury, William Darko, Luke A Probst, Jeffrey M Steele

Ann Pharmacother· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a Standardized Treatment Panel on Hypoglycemic Events in Hospitalized Acute Hyperkalemic Patients Treated With Intravenous Regular Insulin.
Allison Zuern, Luke A Probst, William Darko, Peter Rosher, Christopher D Miller

Hosp Pharm· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is It Truly "Alpha"? Incidence of Thrombotic Events With Andexanet Alfa at a Single Academic Medical Center.
Katie A Parsels, Robert W Seabury, William Darko, Luke A Probst, Gregory M Cwikla

Ann Emerg Med· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nephrotoxicity Risk and Clinical Effectiveness of Continuous versus Intermittent Infusion Vancomycin Among Patients in an Outpatient Parenteral Antimicrobial Therapy Program.
Pegah Shakeraneh, Tasaduq Fazili, Dongliang Wang, Tarvinder Gilotra, Jeffrey M Steele, Luke A Probst

Pharmacotherapy· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Verifying Medication Orders in the Older Population: Are We Using Enough Caution?
Ali Scrimenti, Luke A Probst, Christopher D Miller, Kelly R Ulen, John Noviasky

Sr Care Pharm· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a Long-Acting Opioid Restriction Policy: Does Restriction Reduce the Need for Naloxone Reversal?
Jenna L Fancher, Robert W Seabury, William Darko, Luke A Probst, Christopher D Miller

Hosp Pharm· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two High to Start? Targeting a New Starting Dose for Argatroban Infusions.
Taylor R White, Robert W Seabury, William Darko, Luke A Probst, Christopher D Miller

J Pharm Technol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacist recommendations for prophylactic enoxaparin monitoring and dose adjustment in trauma patients admitted to a surgical intensive care unit.
Ali Scrimenti, Robert W Seabury, Christopher D Miller, Lucy Ruangvoravat, William Darko, Luke A Probst

Pharm Pract (Granada)· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Andexanet Alfa: Preferred Treatment or Therapeutic Option?
Curtis A Blow, Luke A Probst, Christopher D Miller, Robert W Seabury

P T· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Warfarin Patients with Low Time in Therapeutic Range (TTR) for Transition to Non-Vitamin-K Oral Anticoagulant (NOAC) Therapy.
Lindsey M Fovel, Christopher D Miller, Robert W Seabury, Luke A Probst, Lara Horvath

P T· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Readiness to implement vancomycin monitoring based on area under the concentration-time curve: A cross-sectional survey of a national health consortium.
Wesley D Kufel, Robert W Seabury, Bryan T Mogle, Mario V Beccari, Luke A Probst

Am J Health Syst Pharm· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Warfarin Patients with Low Time in Therapeutic Range (TTR) for Transition to Non-Vitamin-K Oral Anticoagulant (NOAC) Therapy.
Lindsey M Fovel, Christopher D Miller, Robert W Seabury, Luke A Probst, Lara Horvath

P T· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonidine for Dexmedetomidine Withdrawal in Pediatric Patients: A Single Center's Experience.
Erin R Beitz, Robert Seabury, Christopher D Miller, William Q Darko, Luke A Probst

J Pediatr Pharmacol Ther· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of premix antimicrobial preparation and time to administration in septic patients.
Wesley D Kufel, Robert W Seabury, Gregory M Meola, William Darko, Luke A Probst

CJEM· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Pharmacy Residency Training Design Between 2012 and 2017: A Perspective of Academic Medical Centers.
Anne Krasniak, William Darko, Christopher D Miller, Robert Seabury, Luke A Probst

Hosp Pharm· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of a Combination Antibiotic Bag on Compliance With Surviving Sepsis Campaign Goals in Emergency Department Patients With Severe Sepsis and Septic Shock.
Michael P Lorenzo, Lindsay MacConaghy, Christopher D Miller, Gregory Meola, Luke A Probst

Ann Pharmacother· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Price-Performance Ratio Analysis Of Enteral Vitamin K Formulations.
Patrick Rose, Gregory Cwikla, Christopher Miller, Luke Probst, Robert Seabury

P T· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis